Growth Metrics

Solid Biosciences (SLDB) Equity Average (2018 - 2026)

Quarterly results put Equity Average at $277.1 million for Q1 2026, up 28.36% from a year ago — trailing twelve months through Mar 2026 was $277.1 million (up 28.36% YoY), and the annual figure for FY2025 was $158.6 million, up 20.3%.

Solid Biosciences has reported Equity Average over the past 9 years, most recently at $277.1 million for Q1 2026.

  • Equity Average reached $277.1 million in Q1 2026 per SLDB's latest filing, up from $199.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $277.1 million in Q1 2026 and bottomed at $135.4 million in Q4 2023.
  • Median Equity Average over the past 5 years was $180.1 million (2024), compared with a mean of $192.4 million.
  • The largest annual shift saw Equity Average crashed 33.77% in 2022 before it skyrocketed 36.83% in 2025.
  • Over 5 years, Equity Average stood at $177.5 million in 2022, then decreased by 23.69% to $135.4 million in 2023, then grew by 12.34% to $152.1 million in 2024, then surged by 30.79% to $199.0 million in 2025, then skyrocketed by 39.25% to $277.1 million in 2026.
  • Business Quant data shows Equity Average for SLDB at $277.1 million in Q1 2026, $199.0 million in Q4 2025, and $238.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 3.76 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 21.35 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 19.01 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 31.34 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 932.28 Mn
10 Solid Biosciences 713.77 Mn 333.09 Mn - 277.07 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 277.07 Mn
Dec 31, 2025 198.98 Mn
Sep 30, 2025 238.12 Mn
Jun 30, 2025 276.38 Mn
Mar 31, 2025 215.85 Mn
Dec 31, 2024 152.13 Mn
Sep 30, 2024 180.13 Mn
Jun 30, 2024 201.98 Mn
Mar 31, 2024 168.60 Mn
Dec 31, 2023 135.42 Mn
Sep 30, 2023 154.04 Mn
Jun 30, 2023 173.76 Mn
Mar 31, 2023 197.73 Mn
Dec 31, 2022 177.47 Mn
Sep 30, 2022 152.76 Mn
Jun 30, 2022 173.87 Mn
Mar 31, 2022 196.86 Mn
Dec 31, 2021 215.79 Mn
Sep 30, 2021 230.65 Mn
Jun 30, 2021 245.47 Mn
Mar 31, 2021 192.54 Mn
Dec 31, 2020 77.16 Mn
Sep 30, 2020 31.47 Mn
Jun 30, 2020 48.58 Mn
Mar 31, 2020 68.25 Mn
Dec 31, 2019 94.29 Mn
Sep 30, 2019 92.51 Mn
Jun 30, 2019 87.80 Mn
Mar 31, 2019 112.15 Mn
Dec 31, 2018 135.13 Mn
Sep 30, 2018 153.68 Mn
Jun 30, 2018 170.62 Mn
Mar 31, 2018 59.85 Mn